Baseline characteristics

Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism · Source last updated 2019-09-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms

1. counts

   1. group Id

      BG000

      value

      11

   2. group Id

      BG001

      value

      11

   3. group Id

      BG002

      value

      11

   4. group Id

      BG003

      value

      33

   units

   Participants

groups

1. description

   Enrolled patients were randomized to 20mg pasireotide LAR.

   id

   BG000

   title

   Pasireotide LAR 20mg

2. description

   Enrolled patients were randomized to 40mg pasireotide LAR.

   id

   BG001

   title

   Pasireotide LAR 40mg

3. description

   Enrolled patients were randomized to 60mg pasireotide LAR.

   id

   BG002

   title

   Pasireotide LAR 60mg

4. description

   Total of all reporting groups

   id

   BG003

   title

   Total

measures

1. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            spread

            11.48

            value

            57.2

         2. group Id

            BG001

            spread

            13.75

            value

            49.1

         3. group Id

            BG002

            spread

            14.60

            value

            46.6

         4. group Id

            BG003

            spread

            13.71

            value

            51.0

   dispersion Type

   STANDARD_DEVIATION

   param Type

   MEAN

   population Description

   Full analysis set comprises all patients to whom study treatment had been assigned by randomization.

   title

   Age, Continuous

   unit Of Measure

   Years

2. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            4

         2. group Id

            BG001

            value

            7

         3. group Id

            BG002

            value

            2

         4. group Id

            BG003

            value

            13

         title

         Female

      2. measurements

         1. group Id

            BG000

            value

            7

         2. group Id

            BG001

            value

            4

         3. group Id

            BG002

            value

            9

         4. group Id

            BG003

            value

            20

         title

         Male

   param Type

   COUNT_OF_PARTICIPANTS

   population Description

   Full analysis set comprises all patients to whom study treatment had been assigned by randomization.

   title

   Sex: Female, Male

   unit Of Measure

   Participants

3. classes

   1. categories

      1. measurements

         1. group Id

            BG000

            value

            11

         2. group Id

            BG001

            value

            11

         3. group Id

            BG002

            value

            11

         4. group Id

            BG003

            value

            33

      title

      Asian

   param Type

   NUMBER

   population Description

   Full analysis set comprises all patients to whom study treatment had been assigned by randomization.

   title

   Race/Ethnicity, Customized

   unit Of Measure

   Participants

population Description

Full analysis set comprises all patients to whom study treatment had been assigned by randomization.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice